Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1985 Oct;54(4):420–427. doi: 10.1136/hrt.54.4.420

Role of calcium in the induction of cardiac hypertrophy and myofibrillar disarray. Experimental studies of a possible cause of hypertrophic cardiomyopathy.

P C Pearcé, C Hawkey, C Symons, E G Olsen
PMCID: PMC481921  PMID: 3931660

Abstract

The role of calcium in the pathogenesis of hypertrophic cardiomyopathy was investigated experimentally. For this purpose the calcium antagonist verapamil and the calcium ionophore A23187 were administered to pregnant rats together with triac in order to observe their effect on triac induced myocardial disarray and hypertrophy in developing rat hearts. At a low dose verapamil reduced both the level of disarray and hypertrophy, but a higher dose produced hypertrophy when given alone. A23187 did not appreciably potentiate the actions of triac when given in combination but when administered alone produced both disarray and hypertrophy. Verapamil prevents the inward movement of calcium ions to the myocardial cell, whereas A23187 increases the inflow of calcium ions. The results suggest that the actions of triac in producing myocardial disarray and hypertrophy are attributable to an increased concentration of intracellular calcium.

Full text

PDF
420

Images in this article

422Image
on p.422
423Image
on p.423
424Image
on p.424
425Image
on p.425

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Becker A. E., Caruso G. Myocardial disarray. A critical review. Br Heart J. 1982 Jun;47(6):527–538. doi: 10.1136/hrt.47.6.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Becker A. E. Myocardial disorganisation in hypertrophic cardiomyopathy. Br Heart J. 1984 Apr;51(4):466–468. doi: 10.1136/hrt.51.4.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bell R., Barber P. V., Bray C. L., Beton D. C. Incidence of thyroid disease in cases of hypertrophic cardiomyopathy. Br Heart J. 1978 Nov;40(11):1306–1309. doi: 10.1136/hrt.40.11.1306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bulkley B. H., Weisfeldt M. L., Hutchins G. M. Isometric cardiac contraction. a possible cause of the disorganized myocardial pattern of idiopathic hypertrophic subaortic stenosis. N Engl J Med. 1977 Jan 20;296(3):135–139. doi: 10.1056/NEJM197701202960303. [DOI] [PubMed] [Google Scholar]
  5. Davies M. J. The current status of myocardial disarray in hypertrophic cardiomyopathy. Br Heart J. 1984 Apr;51(4):361–363. doi: 10.1136/hrt.51.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ferrans V. J., Morrow A. G., Roberts W. C. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation. 1972 Apr;45(4):769–792. doi: 10.1161/01.cir.45.4.769. [DOI] [PubMed] [Google Scholar]
  7. Hawkey C. M., Olsen E. G., Symons C. Production of cardiac muscle abnormalities in offspring of rats receiving triiodothyroacetic acid (triac) and the effect of beta adrenergic blockade. Cardiovasc Res. 1981 Apr;15(4):196–205. doi: 10.1093/cvr/15.4.196. [DOI] [PubMed] [Google Scholar]
  8. Kaltenbach M., Hopf R., Kober G., Bussmann W. D., Keller M., Petersen Y. Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Br Heart J. 1979 Jul;42(1):35–42. doi: 10.1136/hrt.42.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lossnitzer K., Janke J., Hein B., Stauch M., Fleckenstein A. Disturbed myocardial calcium metabolism: a possible pathogenetic factor in the hereditary cardiomyopathy of the Syrian hamster. Recent Adv Stud Cardiac Struct Metab. 1975;6:207–217. [PubMed] [Google Scholar]
  10. Maron B. J., Ferrans V. J., White R. I., Jr Unusual evolution of acquired infundibular stenosis in patients with ventricular septal defect. Clinical and morphologic observations. Circulation. 1973 Nov;48(5):1092–1103. doi: 10.1161/01.cir.48.5.1092. [DOI] [PubMed] [Google Scholar]
  11. Maron B. J. Myocardial disorganisation in hypertrophic cardiomyopathy. Another point of view. Br Heart J. 1983 Jul;50(1):1–3. doi: 10.1136/hrt.50.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Maron B. J., Roberts W. C. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation. 1979 Apr;59(4):689–706. doi: 10.1161/01.cir.59.4.689. [DOI] [PubMed] [Google Scholar]
  13. McKenna W. J., Harris L., Perez G., Krikler D. M., Oakley C., Goodwin J. F. Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. Br Heart J. 1981 Aug;46(2):173–178. doi: 10.1136/hrt.46.2.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nayler W. G. Calcium exchange in cardiac muscle: a basic mechanism of drug action. Am Heart J. 1967 Mar;73(3):379–394. doi: 10.1016/0002-8703(67)90435-8. [DOI] [PubMed] [Google Scholar]
  15. Nayler W. G., Merrillees N. C., Chipperfield D., Kurtz J. B. Influence of hyperthyroidism on the uptake and binding of calcium by cardiac microsomal fractions and on mitochondrial structure. Cardiovasc Res. 1971 Oct;5(4):469–482. doi: 10.1093/cvr/5.4.469. [DOI] [PubMed] [Google Scholar]
  16. Olsen E. G. Myocardial disarray revisited. Br Med J (Clin Res Ed) 1982 Oct 9;285(6347):991–992. doi: 10.1136/bmj.285.6347.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Olsen E. G., Symons C., Hawkey C. Effect of triac on the developing heart. Lancet. 1977 Jul 30;2(8031):221–223. doi: 10.1016/s0140-6736(77)92836-7. [DOI] [PubMed] [Google Scholar]
  18. Pearce P. C., Hawkey C. M., Symons C., Olsen E. G. Effect of triac and beta-adrenergic blocking agents on the myocardium of developing rats. Cardiovasc Res. 1983 Jan;17(1):7–14. doi: 10.1093/cvr/17.1.7. [DOI] [PubMed] [Google Scholar]
  19. Perloff J. K. Pathogenesis of hypertrophic cardiomyopathy: hypotheses and speculations. Am Heart J. 1981 Feb;101(2):219–226. doi: 10.1016/0002-8703(81)90669-4. [DOI] [PubMed] [Google Scholar]
  20. Rosing D. R., Kent K. M., Borer J. S., Seides S. F., Maron B. J., Epstein S. E. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects. Circulation. 1979 Dec;60(6):1201–1207. doi: 10.1161/01.cir.60.6.1201. [DOI] [PubMed] [Google Scholar]
  21. Suko J. The calcium pump of cardiac sarcoplasmic reticulum. Functional alterations at different levels of thyroid state in rabbits. J Physiol. 1973 Feb;228(3):563–582. doi: 10.1113/jphysiol.1973.sp010100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Symons C., Richardson P. J., Feizi O. Hypertrophic cardiomyopathy and hyperthyroidism: a report of three cases. Thorax. 1974 Nov;29(6):713–719. doi: 10.1136/thx.29.6.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. VENABLE J. H., COGGESHALL R. A SIMPLIFIED LEAD CITRATE STAIN FOR USE IN ELECTRON MICROSCOPY. J Cell Biol. 1965 May;25:407–408. doi: 10.1083/jcb.25.2.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Van Noorden S., Olsen E. G., Pearse A. G. Hypertrophic obstructive cardiomyopathy, a histological, histochemical, and ultrastructural study of biopsy material. Cardiovasc Res. 1971 Jan;5(1):118–131. doi: 10.1093/cvr/5.1.118. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES